Advertisement
<< Back To Article
The Trouble With Tropism

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

11 Comments

The deal

Thanks for a great article. I feel well informed.Life has thrown it's share of dirt on me since testing + 15 years ago.But I'm still here and greatful.Please continue to keep me and others INFORMED. Blessings

November 8, 2007 Chicago

June

Very Interesting. Thank you. Any news on how this drug is working on women vs. men? Any differences? Thanks again.

October 7, 2007 Texas

C G

Thanks, very informative, and very well written article to help explain it to the regular, 29 yr olf + joe schmoe.

October 3, 2007 NYC, NY

Martin French

Could blocking both the R5 and X4 receptors simultaneousy prevent the cell from functioning normally? If not, could this theoretically provide a cure for HIV? How far down the pipeline are X4 antagonists?

October 2, 2007

Deneen Robinson

This was a very good explanation of a very complex topic.

October 1, 2007 Dallas

Tim Horn

KB -- Glad you found it interesting... so did we in reporting, writing, and publishing it! -- Tim Horn, Senior Editor, AIDSmed.com

September 28, 2007 New York

Tim Horn

Robert -- It sounds as if you're looking to simplify your current regimen... and it should be noted that Selzentry is a twice-daily option. If you'd like to talk more about your current -- and future -- options, visit the AIDSmeds.com Forums.

September 28, 2007 New York

Tim Horn

LM -- Excellent question. X4 antagonists are still in the early stages of testing, but their potential for use in combination with R5 antagonists is pretty terrific. - Tim Horn, Senior Editor, AIDSmeds.com

September 28, 2007 New York

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.